Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (0874.HK)
HKD 16.84
(-0.71%)
HKD 16.84
(-0.71%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -9.35 Billion CNY | 15.46% |
| 2022 | -11.06 Billion CNY | 11.11% |
| 2021 | -12.45 Billion CNY | -25.67% |
| 2020 | -9.9 Billion CNY | 16.17% |
| 2019 | -11.81 Billion CNY | -23.23% |
| 2018 | -9.59 Billion CNY | 17.7% |
| 2017 | -11.65 Billion CNY | 10.57% |
| 2016 | -13.03 Billion CNY | -277.87% |
| 2015 | -3.44 Billion CNY | -31.62% |
| 2014 | -2.62 Billion CNY | -84.87% |
| 2013 | -1.41 Billion CNY | -119.05% |
| 2012 | -647.06 Million CNY | -170.51% |
| 2011 | -239.2 Million CNY | 64.22% |
| 2010 | -668.52 Million CNY | -5.52% |
| 2009 | -633.56 Million CNY | -487.4% |
| 2008 | -107.85 Million CNY | -153.05% |
| 2007 | 203.31 Million CNY | -49.05% |
| 2006 | 399.07 Million CNY | 32.67% |
| 2005 | 300.8 Million CNY | 40.68% |
| 2004 | 213.81 Million CNY | 1522.67% |
| 2003 | -15.02 Million CNY | 95.99% |
| 2002 | -374.88 Million CNY | 11.74% |
| 2001 | -424.72 Million CNY | -579.01% |
| 2000 | 88.66 Million CNY | -43.76% |
| 1999 | 157.64 Million CNY | -16.43% |
| 1998 | 188.63 Million CNY | 4.5% |
| 1997 | 180.51 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -2.34 Billion CNY | 60.68% |
| 2024 Q3 | -5.12 Billion CNY | -97.23% |
| 2024 Q1 | -5.95 Billion CNY | 36.41% |
| 2023 Q4 | -9.35 Billion CNY | -23.22% |
| 2023 Q3 | -7.59 Billion CNY | 4.63% |
| 2023 Q1 | -7.22 Billion CNY | 34.74% |
| 2023 FY | -9.35 Billion CNY | 15.46% |
| 2023 Q2 | -7.96 Billion CNY | -10.22% |
| 2022 Q3 | -10.37 Billion CNY | 10.91% |
| 2022 FY | -11.06 Billion CNY | 11.11% |
| 2022 Q4 | -11.06 Billion CNY | -6.67% |
| 2022 Q2 | -11.64 Billion CNY | 6.08% |
| 2022 Q1 | -12.4 Billion CNY | 0.39% |
| 2021 Q4 | -12.45 Billion CNY | 6.73% |
| 2021 Q2 | -10.29 Billion CNY | 6.18% |
| 2021 FY | -12.45 Billion CNY | -25.67% |
| 2021 Q3 | -13.35 Billion CNY | -29.66% |
| 2021 Q1 | -10.97 Billion CNY | -10.76% |
| 2020 Q1 | -8.29 Billion CNY | 29.82% |
| 2020 Q3 | -10.37 Billion CNY | -7.89% |
| 2020 Q2 | -9.61 Billion CNY | -15.91% |
| 2020 FY | -9.9 Billion CNY | 16.17% |
| 2020 Q4 | -9.9 Billion CNY | 4.47% |
| 2019 Q2 | -7.89 Billion CNY | -14.42% |
| 2019 Q1 | -6.89 Billion CNY | 28.07% |
| 2019 FY | -11.81 Billion CNY | -23.23% |
| 2019 Q3 | -8.22 Billion CNY | -4.23% |
| 2019 Q4 | -11.81 Billion CNY | -43.66% |
| 2018 FY | -9.59 Billion CNY | 17.7% |
| 2018 Q4 | -9.59 Billion CNY | -21.93% |
| 2018 Q3 | -7.86 Billion CNY | -20.09% |
| 2018 Q2 | -6.55 Billion CNY | 47.97% |
| 2018 Q1 | -12.58 Billion CNY | -8.03% |
| 2017 Q3 | -12.56 Billion CNY | -7.22% |
| 2017 Q4 | -11.65 Billion CNY | 7.21% |
| 2017 FY | -11.65 Billion CNY | 10.57% |
| 2017 Q2 | -11.71 Billion CNY | 12.27% |
| 2017 Q1 | -13.35 Billion CNY | -2.46% |
| 2016 Q3 | -13.48 Billion CNY | -168.16% |
| 2016 Q1 | -4.08 Billion CNY | -18.4% |
| 2016 FY | -13.03 Billion CNY | -277.87% |
| 2016 Q4 | -13.03 Billion CNY | 3.34% |
| 2016 Q2 | -5.02 Billion CNY | -23.13% |
| 2015 Q2 | -3.63 Billion CNY | -27.92% |
| 2015 FY | -3.44 Billion CNY | -31.62% |
| 2015 Q4 | -3.44 Billion CNY | -8.16% |
| 2015 Q3 | -3.18 Billion CNY | 12.17% |
| 2015 Q1 | -2.83 Billion CNY | -8.32% |
| 2014 Q1 | -1.42 Billion CNY | -0.42% |
| 2014 Q4 | -2.62 Billion CNY | 1.02% |
| 2014 FY | -2.62 Billion CNY | -84.87% |
| 2014 Q3 | -2.64 Billion CNY | -12.98% |
| 2014 Q2 | -2.34 Billion CNY | -64.64% |
| 2013 Q3 | -1.38 Billion CNY | 9.21% |
| 2013 Q4 | -1.41 Billion CNY | -2.08% |
| 2013 FY | -1.41 Billion CNY | -119.05% |
| 2013 Q1 | -1.17 Billion CNY | -81.58% |
| 2013 Q2 | -1.52 Billion CNY | -30.18% |
| 2012 Q3 | -702.86 Million CNY | -7.89% |
| 2012 Q4 | -647.06 Million CNY | 7.94% |
| 2012 Q1 | -292.76 Million CNY | -22.39% |
| 2012 FY | -647.06 Million CNY | -170.51% |
| 2012 Q2 | -651.45 Million CNY | -122.51% |
| 2011 Q3 | -243.95 Million CNY | 48.95% |
| 2011 FY | -239.2 Million CNY | 64.22% |
| 2011 Q4 | -239.2 Million CNY | 1.95% |
| 2011 Q2 | -477.85 Million CNY | 20.83% |
| 2011 Q1 | -603.61 Million CNY | 9.71% |
| 2010 Q2 | -732.34 Million CNY | -16.22% |
| 2010 Q3 | -592.91 Million CNY | 19.04% |
| 2010 Q4 | -668.52 Million CNY | -12.75% |
| 2010 Q1 | -630.15 Million CNY | 0.54% |
| 2010 FY | -668.52 Million CNY | -5.52% |
| 2009 FY | -633.56 Million CNY | -487.4% |
| 2009 Q1 | -107.55 Million CNY | 0.28% |
| 2009 Q2 | -368.05 Million CNY | -242.18% |
| 2009 Q3 | -479.17 Million CNY | -30.19% |
| 2009 Q4 | -633.56 Million CNY | -32.22% |
| 2008 Q3 | 14.51 Million CNY | 161.72% |
| 2008 Q2 | -23.51 Million CNY | 80.99% |
| 2008 Q1 | -123.67 Million CNY | -160.83% |
| 2008 Q4 | -107.85 Million CNY | -843.26% |
| 2008 FY | -107.85 Million CNY | -153.05% |
| 2007 Q1 | 473.31 Million CNY | 18.6% |
| 2007 FY | 203.31 Million CNY | -49.05% |
| 2007 Q4 | 203.31 Million CNY | -61.7% |
| 2007 Q3 | 530.85 Million CNY | 18.87% |
| 2007 Q2 | 446.59 Million CNY | -5.65% |
| 2006 Q3 | 402.4 Million CNY | 55.66% |
| 2006 Q2 | 258.5 Million CNY | -26.58% |
| 2006 FY | 399.07 Million CNY | 32.67% |
| 2006 Q1 | 352.09 Million CNY | 17.05% |
| 2006 Q4 | 399.07 Million CNY | -0.83% |
| 2005 Q4 | 300.8 Million CNY | 43.44% |
| 2005 Q3 | 209.71 Million CNY | -14.12% |
| 2005 Q2 | 244.18 Million CNY | 201.47% |
| 2005 Q1 | 80.99 Million CNY | -62.12% |
| 2005 FY | 300.8 Million CNY | 40.68% |
| 2004 Q3 | 41.31 Million CNY | 267.17% |
| 2004 Q4 | 213.81 Million CNY | 417.54% |
| 2004 Q2 | -24.71 Million CNY | 83.13% |
| 2004 FY | 213.81 Million CNY | 1522.67% |
| 2004 Q1 | -146.51 Million CNY | -874.89% |
| 2003 Q2 | -224.42 Million CNY | 49.38% |
| 2003 Q3 | -192.45 Million CNY | 14.24% |
| 2003 Q4 | -15.02 Million CNY | 92.19% |
| 2003 FY | -15.02 Million CNY | 95.99% |
| 2003 Q1 | -443.34 Million CNY | -18.26% |
| 2002 Q4 | -374.88 Million CNY | -11.7% |
| 2002 Q1 | -475.53 Million CNY | -11.96% |
| 2002 Q2 | -350.21 Million CNY | 26.35% |
| 2002 Q3 | -335.62 Million CNY | 4.17% |
| 2002 FY | -374.88 Million CNY | 11.74% |
| 2001 Q2 | -682.38 Million CNY | 0.0% |
| 2001 FY | -424.72 Million CNY | -579.01% |
| 2001 Q4 | -424.72 Million CNY | 0.0% |
| 2000 FY | 88.66 Million CNY | -43.76% |
| 2000 Q4 | 88.66 Million CNY | 0.0% |
| 1999 FY | 157.64 Million CNY | -16.43% |
| 1998 FY | 188.63 Million CNY | 4.5% |
| 1997 FY | 180.51 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | -258.7 Million HKD | -3517.302% |
| Grand Pharmaceutical Group Limited | 2.03 Billion HKD | 560.567% |
| Extrawell Pharmaceutical Holdings Limited | 5.94 Million HKD | 157537.242% |
| Wai Yuen Tong Medicine Holdings Limited | 301.53 Million HKD | 3203.467% |
| Qianhai Health Holdings Limited | -19.03 Million HKD | -49054.689% |
| Lee's Pharmaceutical Holdings Limited | 30.94 Million HKD | 30338.043% |
| Essex Bio-Technology Limited | -219.22 Million HKD | -4168.627% |
| Tongfang Kontafarma Holdings Limited | 256.16 Million HKD | 3753.156% |
| PuraPharm Corporation Limited | 377.54 Million HKD | 2578.637% |
| SSY Group Limited | 1.71 Billion HKD | 646.13% |
| JBM (Healthcare) Limited | -7.39 Million HKD | -126377.493% |
| Jacobson Pharma Corporation Limited | 337.44 Million HKD | 2873.238% |
| China Resources Pharmaceutical Group Limited | 50.97 Billion HKD | 118.357% |